Yield and clinical impact of blood cultures in patients admitted to an internal medicine ward.


Journal

Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961

Informations de publication

Date de publication:
01 03 2020
Historique:
entrez: 16 3 2020
pubmed: 17 3 2020
medline: 28 11 2020
Statut: ppublish

Résumé

The purpose of this prospective observational study was to evaluate the yield and clinical impact of blood cultures in a 78-bed Internal Medicine ward of a medium-sized Italian acute care hospital. During a two-month study period, 154 (mean age: 75.2 ++ 12.2 years; 94 males) out of 620 (24.8%) hospitalized patients underwent 174 blood cultures and were enrolled in the study. The rate of true-positive cultures was 11.5% (20/174) and the rate of false-positive (contaminants) was 5.7% (10/174). A total of 23 microorganisms (5 multidrug resistant strains), most frequently Escherichia coli (n = 10), Klebsiella pneumoniae (n = 3) and Staphylococcus aureus (n = 3), were isolated. The positivity rate was significantly higher in patients with urinary tract infection (31%) and abdomen infection (26.1%) than in patients with pneumonia (4.9%; p<0.01). Although the positivity rate in patients exposed to antibiotics was lower than in those not exposed, the difference was not statistically significant. Therapy changes due to blood culture positivity were observed in 7.1% of the patients overall. In-hospital death was observed in nine of the 136 patients with negative blood cultures (6.6%) and in none of the 18 patients with positive blood cultures. These results indicate that the yield and clinical impact of blood cultures is quite low in patients admitted to an Internal Medicine ward and suggest the need to improve the adequacy of the indications to perform the test.

Identifiants

pubmed: 32172261

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-63

Auteurs

Alberto Fortini (A)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Antonio Faraone (A)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Michael Bettucchi (M)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Alice Poggi (A)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Simona Filetti (S)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Costanza Boccadori (C)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Serena Sbaragli (S)

Internal Medicine, San Giovanni di Dio Hospital, Firenze, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH